Skip to main content

Table 1 Clinical information of each ECM cluster in TCGA-BRCA cohort

From: Transcriptome-wide analysis reveals potential roles of CFD and ANGPTL4 in fibroblasts regulating B cell lineage for extracellular matrix-driven clustering and novel avenues for immunotherapy in breast cancer

 

Level

C1

C2

C3

P

n

 

458

367

201

 

Subtype (%)

Basal

1 (0.2)

69 (18.8)

112 (55.7)

< 0.001

Her2

0 (0.0)

50 (13.6)

24 (11.9)

 

LumA

370 (80.8)

138 (37.6)

29 (14.4)

 

LumB

77 (16.8)

97 (26.4)

20 (10.0)

 

Normal

10 (2.2)

13 (3.5)

16 (8.0)

 

T_stage (%)

T1

141 (30.8)

90 (24.5)

48 (23.9)

0.001

T2

242 (52.8)

240 (65.4)

131 (65.2)

 

T3

75 (16.4)

37 (10.1)

22 (10.9)

 

N_stage (%)

LN_Negative

224 (49.6)

161 (44.7)

109 (55.1)

0.061

LN_Positive

228 (50.4)

199 (55.3)

89 (44.9)

 

Age (%)

< = 35

7 (1.5)

15 (4.1)

11 (5.5)

0.003

> = 60

235 (51.3)

161 (43.9)

78 (38.8)

 

35 ~ 60

216 (47.2)

191 (52.0)

112 (55.7)

Â